CN106389139A - Acne-removing, mark-eliminating and skin-protecting multifunctional preparation and preparation method thereof - Google Patents
Acne-removing, mark-eliminating and skin-protecting multifunctional preparation and preparation method thereof Download PDFInfo
- Publication number
- CN106389139A CN106389139A CN201611027865.2A CN201611027865A CN106389139A CN 106389139 A CN106389139 A CN 106389139A CN 201611027865 A CN201611027865 A CN 201611027865A CN 106389139 A CN106389139 A CN 106389139A
- Authority
- CN
- China
- Prior art keywords
- acid
- acne
- eliminating
- removing acne
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010000496 acne Diseases 0.000 title claims abstract description 151
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 150
- 238000002360 preparation method Methods 0.000 title claims abstract description 38
- 239000000203 mixture Substances 0.000 claims abstract description 129
- 239000002904 solvent Substances 0.000 claims abstract description 50
- 108010035532 Collagen Proteins 0.000 claims abstract description 32
- 102000008186 Collagen Human genes 0.000 claims abstract description 32
- 229920001436 collagen Polymers 0.000 claims abstract description 31
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 claims abstract description 29
- 238000000034 method Methods 0.000 claims abstract description 21
- 238000005516 engineering process Methods 0.000 claims abstract description 14
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims abstract description 4
- XJLXINKUBYWONI-NNYOXOHSSA-N NADP zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-N 0.000 claims abstract description 3
- 108010020346 Polyglutamic Acid Proteins 0.000 claims description 84
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 46
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 45
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 claims description 44
- 229940014041 hyaluronate Drugs 0.000 claims description 44
- 229920002643 polyglutamic acid Polymers 0.000 claims description 44
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 38
- 229920000370 gamma-poly(glutamate) polymer Polymers 0.000 claims description 38
- 229920002674 hyaluronan Polymers 0.000 claims description 38
- 229960003160 hyaluronic acid Drugs 0.000 claims description 38
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 38
- 239000002994 raw material Substances 0.000 claims description 38
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 34
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 32
- 150000002148 esters Chemical class 0.000 claims description 31
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 30
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 30
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 24
- 239000004310 lactic acid Substances 0.000 claims description 19
- 235000014655 lactic acid Nutrition 0.000 claims description 19
- 229960000448 lactic acid Drugs 0.000 claims description 19
- 150000003839 salts Chemical class 0.000 claims description 18
- 239000004202 carbamide Substances 0.000 claims description 17
- 238000009472 formulation Methods 0.000 claims description 17
- 229940045136 urea Drugs 0.000 claims description 17
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 16
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 16
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 16
- 241000219095 Vitis Species 0.000 claims description 16
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 16
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 16
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 16
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 16
- 235000011187 glycerol Nutrition 0.000 claims description 16
- 229940001447 lactate Drugs 0.000 claims description 16
- 239000004334 sorbic acid Substances 0.000 claims description 16
- 235000010199 sorbic acid Nutrition 0.000 claims description 16
- 229940075582 sorbic acid Drugs 0.000 claims description 16
- 239000011975 tartaric acid Substances 0.000 claims description 16
- 229960001367 tartaric acid Drugs 0.000 claims description 16
- 235000002906 tartaric acid Nutrition 0.000 claims description 16
- 235000014101 wine Nutrition 0.000 claims description 16
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 15
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims description 15
- 229960000458 allantoin Drugs 0.000 claims description 15
- 229960004106 citric acid Drugs 0.000 claims description 15
- 235000015165 citric acid Nutrition 0.000 claims description 15
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 15
- 239000001685 glycyrrhizic acid Substances 0.000 claims description 15
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 15
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 15
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 15
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 15
- 235000001968 nicotinic acid Nutrition 0.000 claims description 15
- 229960003512 nicotinic acid Drugs 0.000 claims description 15
- 239000011664 nicotinic acid Substances 0.000 claims description 15
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 15
- 229960003080 taurine Drugs 0.000 claims description 15
- 229920001285 xanthan gum Polymers 0.000 claims description 15
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 14
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 14
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 14
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 14
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 14
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 14
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 14
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 14
- 229920000669 heparin Polymers 0.000 claims description 14
- 239000001630 malic acid Substances 0.000 claims description 14
- 229940099690 malic acid Drugs 0.000 claims description 14
- 235000011090 malic acid Nutrition 0.000 claims description 14
- 235000005152 nicotinamide Nutrition 0.000 claims description 14
- 239000011570 nicotinamide Substances 0.000 claims description 14
- 229960003966 nicotinamide Drugs 0.000 claims description 14
- 239000000661 sodium alginate Substances 0.000 claims description 14
- 235000010413 sodium alginate Nutrition 0.000 claims description 14
- 229940005550 sodium alginate Drugs 0.000 claims description 14
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 13
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 13
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 13
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 13
- 229960004889 salicylic acid Drugs 0.000 claims description 13
- 239000002202 Polyethylene glycol Substances 0.000 claims description 11
- 229920001223 polyethylene glycol Polymers 0.000 claims description 11
- -1 Acyl salicylic acid Chemical compound 0.000 claims description 9
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- JJBCTCGUOQYZHK-UHFFFAOYSA-N 2-acetyloxybenzoate;(5-amino-1-carboxypentyl)azanium Chemical compound OC(=O)C(N)CCCC[NH3+].CC(=O)OC1=CC=CC=C1C([O-])=O JJBCTCGUOQYZHK-UHFFFAOYSA-N 0.000 claims description 8
- FXXXGQLMXDIPQA-VWMHFEHESA-N 2-acetyloxybenzoic acid;(2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N.CC(=O)OC1=CC=CC=C1C(O)=O FXXXGQLMXDIPQA-VWMHFEHESA-N 0.000 claims description 8
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims description 7
- 229960001138 acetylsalicylic acid Drugs 0.000 claims description 7
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 6
- 235000013922 glutamic acid Nutrition 0.000 claims description 6
- 239000004220 glutamic acid Substances 0.000 claims description 6
- VYMUGTALCSPLDM-UHFFFAOYSA-L carbasalate calcium Chemical compound [Ca+2].NC(N)=O.CC(=O)OC1=CC=CC=C1C([O-])=O.CC(=O)OC1=CC=CC=C1C([O-])=O VYMUGTALCSPLDM-UHFFFAOYSA-L 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- 235000020095 red wine Nutrition 0.000 claims description 4
- 229910001220 stainless steel Inorganic materials 0.000 claims description 4
- 239000010935 stainless steel Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 235000020097 white wine Nutrition 0.000 claims description 4
- ZGZWRSASDRZAIL-UHFFFAOYSA-N 2-acetyloxybenzoic acid;azane Chemical compound N.CC(=O)OC1=CC=CC=C1C(O)=O ZGZWRSASDRZAIL-UHFFFAOYSA-N 0.000 claims description 3
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 claims description 3
- BTZJQYVYGCCNHY-UHFFFAOYSA-N calcium;urea Chemical compound [Ca].NC(N)=O BTZJQYVYGCCNHY-UHFFFAOYSA-N 0.000 claims description 3
- 239000000701 coagulant Substances 0.000 claims description 3
- 239000000839 emulsion Substances 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 229930195712 glutamate Natural products 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 239000013557 residual solvent Substances 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 229940098465 tincture Drugs 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 2
- 230000001804 emulsifying effect Effects 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims description 2
- 238000001764 infiltration Methods 0.000 claims description 2
- 239000012669 liquid formulation Substances 0.000 claims description 2
- 229920001610 polycaprolactone Polymers 0.000 claims description 2
- 239000004632 polycaprolactone Substances 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims 2
- 239000006072 paste Substances 0.000 claims 2
- 239000000725 suspension Substances 0.000 claims 2
- FMBVHKPWDJQLNO-UHFFFAOYSA-N 1-[(3-fluorophenyl)methyl]-5-nitroindazole Chemical compound N1=CC2=CC([N+](=O)[O-])=CC=C2N1CC1=CC=CC(F)=C1 FMBVHKPWDJQLNO-UHFFFAOYSA-N 0.000 claims 1
- 239000010408 film Substances 0.000 claims 1
- 235000015110 jellies Nutrition 0.000 claims 1
- 239000008274 jelly Substances 0.000 claims 1
- 229920002627 poly(phosphazenes) Polymers 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 30
- 235000016709 nutrition Nutrition 0.000 abstract description 6
- 230000035764 nutrition Effects 0.000 abstract description 6
- 230000008569 process Effects 0.000 abstract description 5
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 238000003912 environmental pollution Methods 0.000 abstract description 3
- 230000037311 normal skin Effects 0.000 abstract description 3
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 2
- 208000026935 allergic disease Diseases 0.000 abstract description 2
- 230000007815 allergy Effects 0.000 abstract description 2
- 238000005265 energy consumption Methods 0.000 abstract description 2
- 238000012423 maintenance Methods 0.000 abstract description 2
- 231100000252 nontoxic Toxicity 0.000 abstract description 2
- 230000003000 nontoxic effect Effects 0.000 abstract description 2
- 229940088594 vitamin Drugs 0.000 abstract description 2
- 235000013343 vitamin Nutrition 0.000 abstract description 2
- 239000011782 vitamin Substances 0.000 abstract description 2
- 229930003231 vitamin Natural products 0.000 abstract description 2
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 abstract 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 abstract 1
- 235000017471 coenzyme Q10 Nutrition 0.000 abstract 1
- 229940110767 coenzyme Q10 Drugs 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 229950006238 nadide Drugs 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
- 230000036559 skin health Effects 0.000 abstract 1
- 230000017423 tissue regeneration Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 109
- 239000002253 acid Substances 0.000 description 17
- 235000019441 ethanol Nutrition 0.000 description 14
- 230000003255 anti-acne Effects 0.000 description 11
- 239000003814 drug Substances 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- 206010061218 Inflammation Diseases 0.000 description 7
- 241000219000 Populus Species 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 230000000035 biogenic effect Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 241001635598 Enicostema Species 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010027626 Milia Diseases 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- 229920002538 Polyethylene Glycol 20000 Polymers 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000000969 egg white Anatomy 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 238000007639 printing Methods 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 210000001732 sebaceous gland Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- JJBCTCGUOQYZHK-ZSCHJXSPSA-N 2-acetyloxybenzoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound NCCCC[C@H](N)C(O)=O.CC(=O)OC1=CC=CC=C1C(O)=O JJBCTCGUOQYZHK-ZSCHJXSPSA-N 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 206010057040 Temperature intolerance Diseases 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001775 anti-pathogenic effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 229940030495 antiandrogen sex hormone and modulator of the genital system Drugs 0.000 description 1
- 239000000164 antipsychotic agent Substances 0.000 description 1
- 229940005529 antipsychotics Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000008543 heat sensitivity Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 1
- 208000017983 photosensitivity disease Diseases 0.000 description 1
- 231100000434 photosensitization Toxicity 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 229940055019 propionibacterium acne Drugs 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 150000004492 retinoid derivatives Chemical class 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000037204 skin physiology Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/723—Xanthans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/734—Alginic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
- A61K8/355—Quinones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/733—Alginic acid; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/88—Polyamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses an acne-removing, mark-eliminating and skin-protecting multifunctional preparation with both acne-removing and mark-eliminating effects and skin-beautifying and skin-protecting effects and a preparation method thereof. The acne-removing, mark-eliminating and skin-protecting multifunctional preparation is composed of a skin care composition, an acne-removing and mark-eliminating composition and a solvent, and not only contains collagen, vitamins and other various nutrients required for normal skin nutrition, but also contains a coenzyme I, a coenzyme II, nicotinamide, a coenzyme Q10 and other healthcare components required for skin health maintenance. The acne-removing, mark-eliminating and skin-protecting multifunctional preparation not only has disinfection, anticorrosion and anti-bacterium components, but also has injured tissue repair components, and the effective combination of the multiple components can generate mild acne-removing and mark-eliminating effects; the acne-removing, mark-eliminating and skin-protecting multifunctional preparation has the advantages of being high in safety, convenient to use, wide in application range, excellent in effect and the like. The acne-removing, mark-eliminating and skin-protecting multifunctional preparation disclosed by the invention is non-toxic, free from irritation and allergy and almost suitable for all people. The preparation method of the acne-removing, mark-eliminating and skin-protecting multifunctional preparation, disclosed by the invention, has the advantages of mild condition, no need of temperature rise, low energy consumption, simple and short process flow and no environmental pollution, and is a green manufacturing technology that is worth of being popularized.
Description
Technical field
The invention belongs to cosmetics and technical field of medicine, relate in particular to a kind of removing acne and eliminating mark skin care multi-functional
Preparation and preparation method thereof.
Background technology
Acne is being commonly called as of acne, is " whelk ", " dark sore " or " acne " again, is due to hair follicle and sebum adenemphraxis, sends out
A kind of skin disease that inflammation is caused.The generation of acne is main to be blocked with hypersteatosis, pilosebaceous duct, bacterium infection
Closely related with factors such as inflammatory reactions.Acne(Whelk)Main clinical manifestation be blackhead, Whiteheads, inflammatory mound
Rash, warts, tubercle, tumour, easily form pigmentation, pore is thick or even scar sample damages.Impact is attractive in appearance not to be said, severe patient can
Lead to disfeature, can give people to cause great psychological pressure and mental suffering.Typically speak of the origin cause of formation of acne, be nothing more than diet,
Hormone is inharmonious, pressure or heredity, or 3male hormone secretion excessive, fat secretion is excessive, local inflammation, bacterium sense
Dye, cross-infection, the effect of pathogenic microorganism-Propiobacterium, immune antiboidy effect, allergic, eat animal tallow and sugar more
The gastrointestinal disorders such as group food, indigestion or constipation or skin nursing improper etc. caused by.But no matter which kind of reason, all can return
Become:Acne is a large amount of oil substances and the sweat do not removed in time, dust, germ, acarid etc. in hair follicle and sebaceous glands
Block the sebaceous glands mouth of skin surface, and then cause multiple pathogenic microorganisms(Especially propionibacterium acnes)Amount reproduction is formed
Inflamed papules, warts, multiple scytitises such as tubercle and tumour.
At present, conventional anti-acne method or product are mainly:1st, medicine method:It is divided into external application and oral 2 classes again.Common drug
Have:Tretinoin, antibioticses(Clindamycin, erythromycin, chloramphenicol etc.), sulphur lotion etc.;Anti-androgens;Oral glucose skin
Matter steroids;Chinese medicine class etc.;2nd, Physical:As laser anti-acne art etc..Though medicine method can anti-acne, some poisonous side effect of medicine
Greatly, some effects are undesirable, and most product for resolving poxes be mostly add substantial amounts of oil substances or silicone oil and other have latent
In the organic solvent endangering as matrix and solvent;Although the Physicals such as laser anti-acne art disappear, preferably, this is a kind of to acne effect
Operative treatment, not only performs the operation and inherently can limit the people that a part is unable to undergo to perform the operation, and also a lot of contraindications, such as pregnant woman,
Photosensitization person, to photaesthesia person and used photosensitizer(Retinoid, tetracycline etc.)People, hypertension, diabetic,
Long-term taking some antipsychotics person, take antiphlogistic, depressor person, the person that has solar exposure in two weeks, have inflammation person on face
(The people's majority going out acne has inflammation, because a kind of diseases associated with inflammation that acne inherently inflammation is caused), to operation desired value
Too high person is it is not recommended that do.
In addition, the current all methods producing or preparing anti-acne class product mostly be unable to do without heating(At least it is greater than 60 DEG C)
This unit operates.And heat and not only consume energy and be unfavorable for greatly environmental protection, for safeguarding the life to heat sensitivity component in product for resolving poxes
Reason activity or effect are also unfavorable.
Content of the invention
For solving defect or the deficiency of above-mentioned technology or product, the invention provides a kind of multi-functional system of removing acne and eliminating mark skin care
Agent and preparation method thereof.
The basic ideas of the present invention are first on the premise of ensureing drug safety and skin safe, by common multiple
Acne class thing Producing reason and the parsing of acne body structure, both need to protect based on patient skin, with greater need for anti-acne, anti-acne and reparation
The theory laid equal stress on protection, screening has nutrition and health care and acts on and belong to biogenic or biochemical class, food-borne to skin
, component based on the component of clear efficacy, with generally acknowledge have the derivatives such as salicylic acid and its salt of broad-spectrum high efficacy safety,
Sorbic acid and its salt, glycyrrhizic acid or/and its esters, urea etc. as main disinfection and exfoliating composition, according to skin group
Knit and different material is absorbed or the understanding through rule characteristic and analysis with cell, without tradition tool toxic and side effect or excitant
In the case of medicine, the biogenic or biochemical class component to skin with nutrition and health care effect and removing acne and eliminating mark effect are entered
Row science assembles one group of optimization and not only can protect with skin nutrition but also can combine disappear the gentle of safe multiple-effect of scar pockmark of anti-acne
Thing, then it is made into the skin care removing acne and eliminating mark product formulation of Energy and comfort using certain technology method.
It is an object of the invention to provide a kind of removing acne and eliminating mark skin care multifunctional preparation and preparation method thereof.The present invention dispels
Acne disappears the existing obvious removing acne and eliminating mark effect of trace skin conditioner, and the nutritious effect with protection skin, collection removing acne and eliminating mark and nutrition
It is integrated with protection skin.This removing acne and eliminating mark skin conditioner is to be made up of skin care composition, removing acne and eliminating mark composition and solvent.
This removing acne and eliminating mark skin conditioner contains the hyaluronic acid of high, normal, basic three kinds of different molecular weight sizes or/and hyaluronate, high, normal, basic
The polyglutamic acid of three kinds of different molecular weight sizes or/and polyglutamate, glutamic acid or/and glutamate, collagen, collagen
Protein peptides, Vc, Ve, Vb5, nicotinic acid, niacinamide, DPN, DPN I, chondroitin sulfate, taurine, liquaemin, ubiquinone10, sea
Algae sugar, sodium alginate, xanthans, sorbic acid and its esters, glycyrrhizic acid or/and its esters, salicylic acid or/and salt, acetyl water
Sour, the smart ammonia acetylsalicylic acid of poplar, lysine acetylsalicylate, calcium acetylsalicylate urea, urea, allantoin, lactic acid, lactate, apple
Tartaric acid, tartaric acid, citric acid, polyethylene glycol, glycerine, ethanol, water.Removing acne and eliminating mark skin conditioner of the present invention is easy to use comfortable, effect
Fruit is notable, and the easy simultaneously environmental sound of fabricating technology method.
The present invention is realized in:
The present invention provides a kind of removing acne and eliminating mark skin care multifunctional preparation.The removing acne and eliminating mark skin conditioner of the present invention is by skin care group
Compound, removing acne and eliminating mark composition and solvent are constituted, and wherein, described skin care composition includes high, normal, basic three kinds of different moleculars
The hyaluronic acid of amount size or/and hyaluronate, the polyglutamic acid of high, normal, basic three kinds of different molecular weight sizes or/and polyglutamic
Hydrochlorate, glutamic acid or/and glutamate, collagen, collagen peptide, Vc, Ve, Vb5, nicotinic acid, niacinamide, DPN, coenzyme
II, chondroitin sulfate, taurine, liquaemin, ubiquinone10, trehalose, sodium alginate, xanthans;Described removing acne and eliminating mark combination
Thing include sorbic acid and its esters, glycyrrhizic acid or/and its esters, urea, allantoin, lactic acid, lactate, malic acid, tartaric acid,
Citric acid and salicylic acid or/and salt, acetylsalicylic acid, Arginine Acetylsalicylate, lysine acetylsalicylate, aspirin
Arbitrary or a combination thereof in calcium urea;Described solvent contains grape wine, polyethylene glycol, lactic acid, glycerine, second alcohol and water;Without
In the case of tradition tool toxic and side effect or dripping of irritant drugs, by above-mentioned skin care composition, removing acne and eliminating mark composition and solvent
The science of carrying out assembles and optimizes, then is made into the removing acne and eliminating mark skin conditioner agent of Energy and comfort using certain technology method
Type.Removing acne and eliminating mark skin conditioner of the present invention is easy to use comfortable, effect is significant, and fabricating technology method is simple and to environment no
Evil.
The quality proportioning of skin care composition of the present invention, removing acne and eliminating mark composition and solvent three is:0.1~
98.00: 0.2~99.00: 0.1~99.70;
Wherein, described skin care composition is by following mass percent(%)Raw material composition:The hyalomitome of HMW
Acid or/and hyaluronate 0.1-5.0, the hyaluronic acid of middle-molecular-weihydroxyethyl or/and hyaluronate 0.1-8.0, low-molecular-weight
Hyaluronic acid or/and hyaluronate 0.1-10.0, the polyglutamic acid of HMW or/and polyglutamate 0.1-4.0, in point
The polyglutamic acid of son amount or/and polyglutamate 0.1-6.0, the polyglutamic acid of low-molecular-weight or/and polyglutamate 0.1-
12.0th, collagen 0.01-10.0, collagen peptide 0.01-8.0, Vc 0.01-5.0, Ve 0.01-5.0, Vb50.01-
8.0th, nicotinic acid 0.01-5.0, niacinamide 0.01-5.0, DPN 0.01-2.0, DPN I 0.01-2.0, chondroitin sulfate
0.01-5.0, taurine 0.01-5.0, liquaemin 0.01-5.0, ubiquinone100.01-5.0, trehalose 0.01-9.0, alginic acid
Sodium 0.01-9.0, xanthans 0.01-9.0;
Described removing acne and eliminating mark composition includes following mass fraction(Part)Raw material:Sorbic acid or/and its esters 0.001-
4.0th, glycyrrhizic acid or/and its esters 0.001-4.0, urea 0.01-15.0, allantoin 0.01-15.0, lactate 0.01-5.0,
Citric acid 0.01-5.0, malic acid 0.01-8.0, tartaric acid 0.01-8.0 and salicylic acid or/and its esters 0.001-35.0, second
Acyl salicylic acid 0.001-25.0, Arginine Acetylsalicylate 0.002-30.0, lysine acetylsalicylate 0.002-40.0, A Si
Arbitrary or a combination thereof in woods calcium urea 0.002-40.0;
Solvent of the present invention is by following mass percent(%)Raw material constitute:Grape wine 0.0001-40.0, polyethylene glycol
0.0001-15.0, lactic acid 0.01-5.0, glycerine 0.0001-10.0, ethanol 0.0001-50.0 and water 0.01-99.9.
As a kind of preferred embodiment of this removing acne and eliminating mark skin conditioner, skin care combination in described removing acne and eliminating mark skin conditioner
The quality proportioning of thing, removing acne and eliminating mark composition and solvent three is:0.2~98.00: 0.3~99.00: 0.1~99.50;Its
In, described skin care composition presses following mass percent(%)Raw material composition:The hyaluronic acid of HMW or/and
The hyaluronic acid of hyaluronate 0.1-3.0, the hyaluronic acid of middle-molecular-weihydroxyethyl or/and hyaluronate 0.1-6.0, low-molecular-weight
Or/and the polyglutamic acid of hyaluronate 0.1-8.0, HMW or/and polyglutamate 0.1-3.0, middle-molecular-weihydroxyethyl poly-
Glutamic acid or/and polyglutamate 0.1-5.0, the polyglutamic acid of low-molecular-weight or/and polyglutamate 0.1-6.0, collagen egg
White 0.1-8.0, collagen peptide 0.1-6.0, Vc 0.1-4.0, Ve 0.1-4.0, Vb50.1-6.0, nicotinic acid 0.05-3.0, cigarette
Acid amides 0.05-3.0, DPN 0.05-1.0, DPN I 0.05-1.0, chondroitin sulfate 0.1-3.0, taurine 0.1-2.0,
Liquaemin 0.1-2.0, ubiquinone100.1-3.0, trehalose 0.1-5.0, sodium alginate 0.1-5.0, xanthans 0.1-5.0;
Described removing acne and eliminating mark composition includes following mass fraction(Part)Raw material:Sorbic acid or/and its salt 0. 01-2.0,
Glycyrrhizic acid or/and its esters 0.01-3.0, urea 0.1-10.0, allantoin 0.1-8.0, lactate 0.1-3.0, citric acid 0.1-
3.0th, malic acid 0.1-5.0, tartaric acid 0.1-5.0 and salicylic acid or/and its esters 0.01-20.0, acetylsalicylic acid 0.01-
19.0th, Arginine Acetylsalicylate 0.02-25.0, lysine acetylsalicylate 0.02-30.0, calcium acetylsalicylate urea 0.02-
Arbitrary or a combination thereof in 30.0;
Described solvent is by following mass percent(%)Raw material constitute:Grape wine 0.01-25.0, polyethylene glycol 0.01-
10.0th, lactic acid 0.1-3.0, glycerine 0.01-5.0, ethanol 0.01-30.0 and water 0.1-98.5.
Except minority belongs to biological endogenous property or the derivative beyond the region of objective existence of biochemical class component in the removing acne and eliminating mark skin conditioner component of the present invention,
Other is biological endogenous property, food-borne, clear efficacy component, and wherein, some still constitute skin histology and cell
Basis, and, most components have multiple physiology/pharmacological functions or effect.As hyaluronic acid, polyglutamic acid,
Collagen, collagen peptide, Vc, Ve, Vb5, nicotinic acid, niacinamide, DPN, DPN I, chondroitin sulfate, taurine, liver
Element, lactic acid, lactate, ubiquinone10It is with water and constitute the basis of skin histology and cell or maintain normal skin tissue
Carry out biogenic physiologically active ingredient with cell, meanwhile, they also have anti-aging and moisturizing, anti-oxidant with carry
High skin immunity, antiallergy etc. act on;Glycyrrhizic acid or/and its esters, urea, allantoin, lactate, citric acid, malic acid,
Tartaric acid and salicylic acid or/and salt, acetylsalicylic acid, smart ammonia acetylsalicylic acid, lysine acetylsalicylate, calcium acetylsalicylate
Urea, then in anti-corrosion, sterilization, removing acne and eliminating mark, cutin-softening, to dispel the aspects such as cutin respond well, each group is divided and is dispelled with the use of it
The acne trace effect that disappears is more significantly and rapid;Trehalose and sodium alginate have protection Skin Cell and radiation-resistant work(under adverse circumstance
Energy;Xanthans then has good thickening, attachment and lubrication;Sorbic acid and its esters are well recognized as safe food-level antibacterial
Preservative, is conducive to keeping long-time stability and the quality of product.Said components are carried out science assemble and optimize, using this
Bright described solvent, can be prepared using certain technology method and can disappear in the case of no any wound and misery
Preparation except stupid acne.
The hyaluronic acid of high, normal, basic three kinds of different molecular weight sizes in removing acne and eliminating mark skin conditioner of the present invention or/
Refer to that polymer hyaluronic acid or the molecular weight of hyaluronate are more than 1,800,000 dalton, middle molecule with hyaluronate
The molecular weight of hyaluronic acid or hyaluronate between 1,000,000-1,800,000 dalton, low molecular weight hyaluronic acid
Or the molecular weight of hyaluronate is less than 600,000 dalton.
The polyglutamic acid of described high, normal, basic three kinds of different molecular weight sizes or/and polyglutamate refer to macromolecule polyglutamic
The molecular weight of acid or polyglutamate is more than 1,000,000 dalton, the molecular weight of middle molecule polyglutamic acid or polyglutamate
Between 600,000-1,000,000 dalton, the molecular weight of low molecular weight polycaprolactone glutamic acid or polyglutamate is less than 100,000
Dalton.
Grape wine in described solvent includes red wine and white wine;Preferably, it is that extra dry red wine, half extra dry red wine and half are sweet red
And extra dry white wine, medium dry white wine and half are sweet white;Polyethylene glycol refers to that the molecular weight of more than food-grade is appointing in 200-20000 dalton
One kind or a combination thereof;Lactic acid, glycerine and ethanol are more than food-grade;Water is the above pure water of counter-infiltration level or its distilled water.
In the removing acne and eliminating mark skin conditioner of the present invention, all components are the product of more than commercially available food-grade or medical grade
Product;In addition to above-mentioned composition and solvent, tradition can be adopted as suitably desired to allow the no safe of use in skin care item
Hidden danger composition or additive or carrier or auxiliary material.For example, other whitening agents, NMF, antioxidant, surfactant, alcohol
The materials such as class, water.
The removing acne and eliminating mark skin conditioner formulation of Energy and comfort of the present invention includes liquid formulation and solid formulation, and preferably half
Fluidised form preparation, more preferably water gelling agent;In practical application, can as needed and use Energy and comfort, with
In described removing acne and eliminating mark skin conditioner, composition in addition to the solvents is base-material, then it is acceptable to mix removing acne and eliminating mark skin conditioner of the present invention
Carrier or auxiliary material, the convenient various formulations being suitable for are made using corresponding preparations technology, can be aqua, vina, tincture, suspended
Liquid, emulsion, creme, paste, gel, coagulant liquid, finish, film, spray or patch etc..
Present invention also offers the preparation method of above-mentioned removing acne and eliminating mark skin conditioner, comprise the steps:
(1)Formula as described in this patent and formula ratio weigh each component of skin care and removing acne and eliminating mark composition respectively, standby
With;
(2)Formula as described in this patent and formula ratio weigh each component of this removing acne and eliminating mark skin conditioner solvent for use respectively, often
Standby after temperature or low temperature mixing;
(3)Each component of the skin care composition of formula ratio is added solvent, normal temperature or the low temperature of part formulation amount
Mix, obtain mixture A;
(4)Each component of the removing acne and eliminating mark composition of formula ratio is added solvent, normal temperature or the low temperature of part formulation amount
Mix, obtain mixture B;
(5)Mixture B is slowly added in mixture A, then residual solvent is added thereto, normal temperature or low temperature are equal
Even, obtain final product described removing acne and eliminating mark skin conditioner.
Step(2)(3)(4)(5)Described in normal temperature or cryogenic conditions be preferably less than 42 DEG C, again more preferably less than 21 DEG C
But it is more than 10 DEG C.
Step(2)(3)(4)(5)Described in stir and evenly mix operating condition be preferably in medical stainless steel blender
Two-dimentional mix and blend, more preferably in glass reactor or 316L stainless steel blender three-dimensional hybrid stirring, further preferably for
Emulsifying mode under vacuum is realized.
In practical operation, can as needed and use Energy and comfort, with above-mentioned removing acne and eliminating mark skin conditioner be
Base-material, then mix removing acne and eliminating mark skin conditioner acceptable carrier of the present invention or auxiliary material, using the corresponding preparations technology side of making
Just the various formulations being suitable for.
The present invention, compared with traditional removing acne and eliminating mark method or technique, has following features:
(1)The physiological and pathological life of chemical composition, skin biochemistry and skin physiology characteristic and each vaccination according to skin
Change characteristic and based on the theory of anti-acne skin care again comprehensive prescription design should be carried out;
(2)On removing acne and eliminating mark skin conditioner raw material components select, based on the consideration of security first principle, skin used by the present invention
Maintenance raw material belongs to biological endogenous property or the derivative beyond the region of objective existence of biochemical class component except minority, and other is biological endogenous property, biochemical class
, food-borne, clear efficacy component, these compositions are mostly natively to have in skin histology or body, only because
With advancing age or other reason causes its content not enough or deficient and so that skin or body immunity is declined and become disease
The susceptible person of substance, wherein, some still constitute the basis of skin histology and cell, and, most components have
Multiple physiology/pharmacological functions simultaneously have good protective effect to skin.So, both provided for skin tissue cell enough
Component needed for nutrition, has the function of multiple protective skin again;
(3)It is based on and removing acne and eliminating mark should also want skin friendly or toxic and side effect or irritating former is not produced to body or skin
Then, on removing acne and eliminating mark raw material components select, existing sterilization anti-corrosive antibacterial antipathogenic composition, have again and repair damaged tissues composition, two
The efficient combination of person can produce gentle removing acne and eliminating mark effect;Especially with the using cooperatively of skin care composition, gentle anti-acne
The trace that disappears effect is more notable;
(4)The solvent of the present invention is unique, is to be made up of various ingredients such as grape wine, polyethylene glycol, lactic acid, glycerine, second alcohol and waters,
Both can dissolve water-soluble component, also can dissolve water-msoluble ingredients, such solvent constitute can ensure that raw materials used wherein
There is good dissolubility;
(5)The preparation method mild condition of removing acne and eliminating mark skin conditioner of the present invention, process is simple, non-environmental-pollution.Due to the present invention
Raw materials used mostly be biochemical class component, more sensitive to physical and chemical factors such as high temperature and illumination, so, by component preferably and technique
Optimize, establish a kind of process is simple, no environment that can prepare removing acne and eliminating mark skin conditioner of the present invention under normal temperature or low temperature
The technical method of pollution;
(6)By the optimum organization of formula and gentle process of preparing using not only successfully solving in this patent prescription
Labile active ingredient such as Vc etc. easily decomposes, oxidizable, allochroic problem, also solves various active composition and mixes
The various stability problems being likely to occur, as stable, thermally-stabilised in light etc., and allow each component produce collaborative or synergistic effect;
(7)Removing acne and eliminating mark skin conditioner of the present invention existing anti-acne effect, also skin makeup skin care effect, also can be to the skin near acne
Carry out prophylactic disinfection in case its further diffusive transport, its core feature is that have protectiveness to normal skin, and to acne
Then there is the depth property dispelled;
(8)This removing acne and eliminating mark skin conditioner can quickly penetrate in acne body portion and its surrounding skin tissue, thoroughly kill or suppression epidermis,
Pathogen in corium and subcutaneous tissue cell, and form efficient protective layer in skin surface, prevent the invasion and attack again of pathogen
And infection, and can deep layer nourishes rough skin.
Long-term result of practical application shows, the present invention has the advantages that in a large number:
(1)Removing acne and eliminating mark is gentle, hurtless measure no pain.In the formula of this removing acne and eliminating mark skin conditioner, become containing multiple foster skin skin cares
Point if hyaluronic acid, collagen, vitamin etc. are it is ensured that skin friendly while removing acne and eliminating mark;
(2)Easy to use, excellent effect.Only smear acne body 1-3 time daily with this removing acne and eliminating mark skin conditioner, 2 days take effect, and are within 2 weeks
One course for the treatment of, the 3-5 course for the treatment of can thoroughly eliminate stupid acne, and does not stay scar, also user's fitness skin;
(3)Safe, widely applicable.Removing acne and eliminating mark skin conditioner of the present invention is nontoxic, non-stimulated, no allergy is it is adaptable to almost institute
There is crowd;
(4)Simple production process, production cost is relatively low;
(5)The preparation method mild condition of removing acne and eliminating mark skin conditioner of the present invention, need not heat up, energy consumption low, technological process is short, and no
Environmental pollution, is a kind of green manufacture technology being worthy to be popularized.
The trial effect of people volunteer is as follows:
(1)Case selection:Randomly choose 78 patients, wherein, the male sex 38, women 40, age 14-50 year, average age
25 years old.Selected acne body size differs in size from the grain of rice to pea, extremely even has more than iblet individually big.
(2)Diagnostic criteria:With reference to nineteen ninety-five《People's Republic of China's traditional Chinese medicine industry standard》Judge.Clinical manifestation is black
Head acne, Whiteheads, inflamed papules, warts, tubercle, tumour person all have.
(3)Treatment method:Use daily removing acne and eliminating mark skin conditioner spot printing acne body 2-3 time, at least sooner or later each 1 time, if middle use
Water-wash away or touch off and need to add 1 time to ensure there is removing acne and eliminating mark skin conditioner all the time on acne body, 1-3 after smearing for the first time, can be massaged
Minute to promote to absorb, then again spot printing once to increase dose, 2 days take effect, be within 2 weeks a course for the treatment of, general treatment 2 is treated
Journey, according to the state of an illness, acne body bigot can be continuously using the 4-6 course for the treatment of.
(4)Criterion of therapeutical effect:No substantially pockmark person is disappeared for recovery from illness with acne body, the acne body 60-70% that disappears is effective, and acne body disappears
It is effective for moving back 40-50%, acne unchanged or disappear less than 10% be invalid.
(5)Treatment results:In 78, fully recover 56, effective 15, effective 6, invalid 1, cure rate 71.8%, effective
Rate 19.2%, efficient 7.7%, inefficiency 1.3%, total effective rate 98.7%.
Specific embodiment
With reference to embodiment, the present invention is described in detail:
Embodiment l:
Formula:
In described removing acne and eliminating mark skin conditioner, the quality proportioning of skin care composition, removing acne and eliminating mark composition and solvent three is:
0.10∶0.20∶99.70;
Wherein, described skin care composition is by following mass percent(%)Raw material composition:The hyalomitome of HMW
Acid or/and the hyaluronic acid of hyaluronate 0.1, the hyaluronic acid of middle-molecular-weihydroxyethyl or/and hyaluronate 8.0, low-molecular-weight
Or/and the polyglutamic acid of hyaluronate 0.1, HMW or/and polyglutamate 0.1, the polyglutamic acid of middle-molecular-weihydroxyethyl or/
With polyglutamate 6.0, the polyglutamic acid of low-molecular-weight or/and polyglutamate 0.1, collagen 0.01, collagen peptide
8.0、Vc 0.01、Ve 0.01、Vb50.01st, nicotinic acid 0.01, niacinamide 5.0, DPN 2.0, DPN I 0.01, sulfuric acid are soft
Ossein 0.01, taurine 0.01, liquaemin 5.0, ubiquinone100.01st, trehalose 0.01, sodium alginate 0.01;Xanthans 9.0;
Described removing acne and eliminating mark composition includes following mass fraction(Part)Raw material:Sorbic acid or/and its salt 0.001, Radix Glycyrrhizae
Acid or/and its esters 4.0, urea 0.01, allantoin 0.01, lactate 5.0, citric acid 0.01, malic acid 0.01, tartaric acid
0.01 and salicylic acid or/and its esters 0.001, acetylsalicylic acid 25.0, Arginine Acetylsalicylate 0.002, lysine acetyl
Salicylic acid 0.002, calcium acetylsalicylate urea 40.0;
Described solvent is by following mass percent(%)Raw material constitute:Grape wine 0.0001, PEG 20000
0.0001st, lactic acid 5.0, glycerine 0.0001, ethanol 5.0 and water 90.0;
Preparation method:Comprise the steps of:
(1)Formula as described in this patent and formula ratio weigh each component of skin care and removing acne and eliminating mark composition respectively, standby
With;
(2)Formula as described in this patent and formula ratio weigh each component of this removing acne and eliminating mark skin conditioner solvent for use respectively, often
Standby after temperature or low temperature mixing;
(3)Each component of the skin care composition of formula ratio is added solvent, normal temperature or the low temperature of part formulation amount
Mix, obtain mixture A;
(4)Each component of the removing acne and eliminating mark composition of formula ratio is added solvent, normal temperature or the low temperature of part formulation amount
Mix, obtain mixture B;
(5)Mixture B is slowly added in mixture A, then residual solvent is added thereto, normal temperature or low temperature are equal
Even, obtain final product described removing acne and eliminating mark skin conditioner.
Embodiment 2:
Formula:
In described removing acne and eliminating mark skin conditioner, the quality proportioning of skin care composition, removing acne and eliminating mark composition and solvent three is:
8.00∶9.00∶83.00;
Wherein, described skin care composition is by following mass percent(%)Raw material composition:The hyalomitome of HMW
Acid or/and the hyaluronic acid of hyaluronate 5.0, the hyaluronic acid of middle-molecular-weihydroxyethyl or/and hyaluronate 0.1, low-molecular-weight
Or/and the polyglutamic acid of hyaluronate 10.0, HMW or/and the polyglutamic acid of polyglutamate 4.0, middle-molecular-weihydroxyethyl
Or/and the polyglutamic acid of polyglutamate 0.1, low-molecular-weight or/and polyglutamate 12.0, collagen 10.0, collagen egg
White peptide 0.01, Vc 5.0, Ve 5.0, Vb58.0th, nicotinic acid 5.0, niacinamide 0.01, DPN 0.01, DPN I 2.0, sulfuric acid
Chondroitin 5.0, taurine 5.0, liquaemin 0.01, ubiquinone105.0th, trehalose 9.0, sodium alginate 9.0;Xanthans 0.01;
Described removing acne and eliminating mark composition includes following mass fraction(Part)Raw material:Sorbic acid or/and its salt 4.0, glycyrrhizic acid
Or/and its esters 0.0 01, urea 15.0, allantoin 15.0, lactate 0.01, citric acid 5.0, malic acid 8.0, tartaric acid
8.0 and salicylic acid or/and its esters 35.0, acetylsalicylic acid 0.001, Arginine Acetylsalicylate 30.0, lysine acetyl water
Poplar acid 40.0;
Described solvent is by following mass percent(%)Raw material constitute:Grape wine 40.0, polyethylene glycol 2000 15.0, lactic acid
0.01st, glycerine 0.0001, ethanol 10.0 and water 27.0;
Preparation method:With embodiment 1.
Embodiment 3:
Formula:
In described removing acne and eliminating mark skin conditioner, the quality proportioning of skin care composition, removing acne and eliminating mark composition and solvent three is:
15.00∶15.00∶70.00;
Wherein, described skin care composition is by following mass percent(%)Raw material composition:The hyalomitome of HMW
Acid or/and the hyaluronic acid of hyaluronate 1.0, the hyaluronic acid of middle-molecular-weihydroxyethyl or/and hyaluronate 1.0, low-molecular-weight
Or/and the polyglutamic acid of hyaluronate 1.0, HMW or/and polyglutamate 2.0, the polyglutamic acid of middle-molecular-weihydroxyethyl or/
With polyglutamate 2.0, the polyglutamic acid of low-molecular-weight or/and polyglutamate 2.0, collagen 5.0, collagen peptide
4.0、Vc 3.0、Ve 2.50、Vb54.0th, nicotinic acid 2.0, niacinamide 3.0, DPN 1.0, DPN I 1.0, chondroitin sulfate
2.0th, taurine 3.0, liquaemin 2.0, ubiquinone103.0th, trehalose 5.0, sodium alginate 5.0, xanthans 4.0;
Described removing acne and eliminating mark composition includes following mass fraction(Part)Raw material:Sorbic acid or/and its salt 2.0, glycyrrhizic acid
Or/and its esters 0.1, urea 8.0, allantoin 7.0, lactate 3.0, citric acid 3.0, malic acid 4.0, tartaric acid 4.0 and water
Poplar acid or/and its esters 18.0, acetylsalicylic acid 12.50, Arginine Acetylsalicylate 15.0;
Described solvent is by following mass percent(%)Raw material constitute:Grape wine 20.0, PEG400 8.0, lactic acid
3.0th, glycerine 10.0, ethanol 5.0 and water 55.0;
Preparation method:With embodiment 1.
Embodiment 4:
Formula:
In described removing acne and eliminating mark skin conditioner, the quality proportioning of skin care composition, removing acne and eliminating mark composition and solvent three is:
98.00∶1.90∶0.10;
Wherein, described skin care composition is by following mass percent(%)Raw material composition:The hyalomitome of HMW
Acid or/and the hyaluronic acid of hyaluronate 2.50, the hyaluronic acid of middle-molecular-weihydroxyethyl or/and hyaluronate 4.0, low-molecular-weight
Or/and the polyglutamic acid of hyaluronate 5.0, HMW or/and polyglutamate 2.0, the polyglutamic acid of middle-molecular-weihydroxyethyl or/
With polyglutamate 3.0, the polyglutamic acid of low-molecular-weight or/and polyglutamate 6.0, collagen 2.0, collagen peptide
1.0、Vc 1.0、Ve 4.0、Vb51.0th, nicotinic acid 0.5, niacinamide 1.0, DPN 0.1, DPN I 0.2, chondroitin sulfate
2.50th, taurine 1.0, liquaemin 0.5, ubiquinone100.2nd, trehalose 3.0, sodium alginate 2.0, xanthans 2.0;
Described removing acne and eliminating mark composition includes following mass fraction(Part)Raw material:Sorbic acid or/and its salt 1.0, glycyrrhizic acid
Or/and its esters 0.5, urea 5.0, allantoin 1.0, lactate 0.1, citric acid 1.0, malic acid 1.0, tartaric acid 1.0 and water
Poplar acid or/and its esters 10.0, acetylsalicylic acid 0.50;
Described solvent is by following mass percent(%)Raw material constitute:Grape wine 0.1, PEG 8000 0.1, lactic acid
0.1st, glycerine 0.1, ethanol 0.1 and water 99.40;
Preparation method:With embodiment 1.
Embodiment 5:
Formula:
In described removing acne and eliminating mark skin conditioner, the quality proportioning of skin care composition, removing acne and eliminating mark composition and solvent three is:
3.00∶5.00∶92.00;
Wherein, described skin care composition is by following mass percent(%)Raw material composition:The hyalomitome of HMW
Acid or/and the hyaluronic acid of hyaluronate 2.0, the hyaluronic acid of middle-molecular-weihydroxyethyl or/and hyaluronate 3.0, low-molecular-weight
Or/and the polyglutamic acid of hyaluronate 2.0, HMW or/and polyglutamate 2.0, the polyglutamic acid of middle-molecular-weihydroxyethyl or/
With polyglutamate 4.0, the polyglutamic acid of low-molecular-weight or/and polyglutamate 3.0, collagen 3.0, collagen peptide
3.0、Vc 2.0、Ve 1.0、Vb52.0th, nicotinic acid 1.0, niacinamide 2.0, DPN 0.5, DPN I 0.5, chondroitin sulfate
3.0th, taurine 4.0, liquaemin 1.0, ubiquinone100.5th, trehalose 6.0, sodium alginate 6.0, xanthans 6.0;
Described removing acne and eliminating mark composition includes following mass fraction(Part)Raw material:Sorbic acid or/and its salt 0.5, glycyrrhizic acid
Or/and its esters 1.0, urea 2.0, allantoin 2.0, lactate 2.0, citric acid 2.0, malic acid 2.0, tartaric acid 2.0 and water
Poplar acid or/and its esters 4.0;
Described solvent is by following mass percent(%)Raw material constitute:Grape wine 0.1, Macrogol 4000 5, lactic acid 5, sweet
Oil 3, ethanol 15 and water 71.8;
Preparation method:With embodiment 1.
Embodiment 6:
Formula:
In described removing acne and eliminating mark skin conditioner, the quality proportioning of skin care composition, removing acne and eliminating mark composition and solvent three is:
0.50∶99.00∶0.50;
Wherein, described skin care composition is by following mass percent(%)Raw material composition:The hyalomitome of HMW
Acid or/and the hyaluronic acid of hyaluronate 2.50, the hyaluronic acid of middle-molecular-weihydroxyethyl or/and hyaluronate 4.0, low-molecular-weight
Or/and the polyglutamic acid of hyaluronate 5.0, HMW or/and polyglutamate 2.0, the polyglutamic acid of middle-molecular-weihydroxyethyl or/
With polyglutamate 3.0, the polyglutamic acid of low-molecular-weight or/and polyglutamate 6.0, collagen 5.0, collagen peptide
4.0、Vc 2.5、Ve 2.5、Vb54.0th, nicotinic acid 2.5, niacinamide 2.5, DPN 1.0, DPN I 1.0, chondroitin sulfate
2.5th, taurine 2.5, liquaemin 2.5, ubiquinone102.5th, trehalose 4.5, sodium alginate 4.5, xanthans 4.5;
Described removing acne and eliminating mark composition includes following mass fraction(Part)Raw material:Sorbic acid or/and its salt 0.1, glycyrrhizic acid
Or/and its esters 1.5, urea 10.0, allantoin 4.0, lactate 3.0, citric acid 4.0, malic acid 4.0, tartaric acid 4.0 and water
Poplar acid 20.0;
Described solvent is by following mass percent(%)Raw material constitute:Grape wine 0.01, PEG20000 0.05, breast
Acid 0.3, glycerine 0.01, ethanol 50.0 and water 49.1;
Preparation method:With embodiment 1.
Embodiment 7:
Formula:
In described removing acne and eliminating mark skin conditioner, the quality proportioning of skin care composition, removing acne and eliminating mark composition and solvent three is:
6.00∶6.00∶88.00;
Wherein, described skin care composition is by following mass percent(%)Raw material composition:The hyalomitome of HMW
Acid or/and the hyaluronic acid of hyaluronate 4.0, the hyaluronic acid of middle-molecular-weihydroxyethyl or/and hyaluronate 6.0, low-molecular-weight
Or/and the polyglutamic acid of hyaluronate 8.0, HMW or/and polyglutamate 0.5, the polyglutamic acid of middle-molecular-weihydroxyethyl or/
With polyglutamate 0.6, the polyglutamic acid of low-molecular-weight or/and polyglutamate 1.2, collagen 8.0, collagen peptide
6.0、Vc 4.0、Ve 3.0、Vb54.0th, nicotinic acid 2.0, niacinamide 4.0, DPN 0.8, DPN I 0.6, chondroitin sulfate
4.0th, taurine 4.0, liquaemin 4.0, ubiquinone104.0th, trehalose 8.0, sodium alginate 8.0, xanthans 6.0;
Described removing acne and eliminating mark composition includes following mass fraction(Part)Raw material:Sorbic acid or/and its salt 3.0, glycyrrhizic acid
Or/and its esters 2.5, urea 12.0, allantoin 8.0, lactate 4.0, citric acid 0.5, malic acid 1.5, tartaric acid 1.5 and water
Poplar acid sodium;
Described solvent is by following mass percent(%)Raw material constitute:Grape wine 1.0, Macrogol 6000 1.0, lactic acid
1.0th, glycerine 1.0, ethanol 2.0 and water 92.0;
Preparation method:With embodiment 1.
The invention is not restricted to case study on implementation described above.
Claims (10)
1. a kind of removing acne and eliminating mark skin care multifunctional preparation it is characterised in that:This removing acne and eliminating mark skin conditioner is to be combined by skin care
Thing, removing acne and eliminating mark composition and solvent are constituted, and wherein, described skin care composition includes high, normal, basic three kinds of different molecular weights
The hyaluronic acid of size or/and hyaluronate, the polyglutamic acid of high, normal, basic three kinds of different molecular weight sizes or/and polyglutamic acid
Salt, glutamic acid or/and glutamate, collagen, collagen peptide, Vc, Ve, Vb5, nicotinic acid, niacinamide, DPN, coenzyme
II, chondroitin sulfate, taurine, liquaemin, ubiquinone10, trehalose, sodium alginate, xanthans;Described removing acne and eliminating mark combination
Thing include sorbic acid and its esters, glycyrrhizic acid or/and its esters, urea, allantoin, lactic acid, lactate, malic acid, tartaric acid,
Citric acid and salicylic acid or/and salt, acetylsalicylic acid, smart ammonia acetylsalicylic acid, lysine acetylsalicylate, calcium acetylsalicylate
Arbitrary or a combination thereof of urea;Described solvent contains grape wine, lactic acid, polyethylene glycol, glycerine, second alcohol and water;
The quality proportioning of described skin care composition, removing acne and eliminating mark composition and solvent three is:0.1~98.00: 0.2~
99.00: 0.1~99.70;Wherein, described skin care composition is by following mass percent(%)Raw material composition:High
The hyaluronic acid of molecular weight or/and hyaluronate 0.1-5.0, the hyaluronic acid of middle-molecular-weihydroxyethyl or/and hyaluronate 0.1-
8.0th, the hyaluronic acid of low-molecular-weight or/and hyaluronate 0.1-10.0, the polyglutamic acid of HMW or/and polyglutamic acid
Salt 0.1-4.0, the polyglutamic acid of middle-molecular-weihydroxyethyl or/and polyglutamate 0.1-6.0, the polyglutamic acid of low-molecular-weight or/and poly-
Glutamate 0.1-12.0, collagen 0.01-10.0, collagen peptide 0.01-8.0, Vc 0.01-5.0, Ve 0.01-
5.0、Vb50.01-8.0, nicotinic acid 0.01-5.0, niacinamide 0.01-5.0, DPN 0.01-2.0, DPN I 0.01-2.0,
Chondroitin sulfate 0.01-5.0, taurine 0.01-5.0, liquaemin 0.01-5.0, ubiquinone100.01-5.0, trehalose 0.01-
9.0th, sodium alginate 0.01-9.0, xanthans 0.01-9.0;
Described removing acne and eliminating mark composition includes following mass fraction(Part)Raw material:Sorbic acid or/and its esters 0.001-
4.0th, glycyrrhizic acid or/and its esters 0.001-4.0, urea 0.01-15.0, allantoin 0.01-15.0, lactate 0.01-5.0,
Citric acid 0.01-5.0, malic acid 0.01-8.0, tartaric acid 0.01-8.0 and salicylic acid or/and its esters 0.001-35.0, second
Acyl salicylic acid 0.001-25.0, Arginine Acetylsalicylate 0.002-30.0, lysine acetylsalicylate 0.002-40.0, A Si
Arbitrary or a combination thereof in woods calcium urea 0.002-40.0;
Solvent of the present invention is by following mass percent(%)Raw material constitute:Grape wine 0.0001-40.0, polyethylene glycol
0.0001-15.0, lactic acid 0.01-5.0, glycerine 0.0001-10.0, ethanol 0.0001-50.0 and water 0.01-99.9;
Above-mentioned skin care composition, removing acne and eliminating mark composition and solvent are carried out science assemble and optimize, then using certain
Technology method is made into the removing acne and eliminating mark skin conditioner formulation of Energy and comfort.
2. removing acne and eliminating mark skin conditioner according to claim 1 it is characterised in that:This removing acne and eliminating mark skin conditioner is skin care
Composition, removing acne and eliminating mark composition and solvent carry out science and assemble and optimize, then using certain technology method preparation
Become, the more high quality proportioning of described skin care composition, removing acne and eliminating mark composition and solvent three is:0.2~98.00: 0.3
~99.00: 0.1~99.50;Wherein, described skin care composition presses following mass percent(%)Raw material composition:High
The hyaluronic acid of molecular weight or/and hyaluronate 0.1-3.0, the hyaluronic acid of middle-molecular-weihydroxyethyl or/and hyaluronate 0.1-
6.0th, the hyaluronic acid of low-molecular-weight or/and hyaluronate 0.1-8.0, the polyglutamic acid of HMW or/and polyglutamic acid
Salt 0.1-3.0, the polyglutamic acid of middle-molecular-weihydroxyethyl or/and polyglutamate 0.1-5.0, the polyglutamic acid of low-molecular-weight or/and poly-
Glutamate 0.1-6.0, collagen 0.1-8.0, collagen peptide 0.1-6.0, Vc 0.1-4.0, Ve 0.1-4.0, Vb5
0.1-6.0, nicotinic acid 0.05-3.0, niacinamide 0.05-3.0, DPN 0.05-1.0, DPN I 0.05-1.0, chondroitin sulfate
0.1-3.0, taurine 0.1-2.0, liquaemin 0.1-2.0, ubiquinone100.1-3.0, trehalose 0.01-9.0, sodium alginate
0.01-9.0, xanthans 0.1-5.0;
Described removing acne and eliminating mark composition includes following mass fraction(Part)Raw material:Sorbic acid or/and its salt 0. 01-2.0,
Glycyrrhizic acid or/and its esters 0. 01-3.0, urea 0. 1-10.0, allantoin 0. 1-8.0, lactate 0.1-3.0, citric acid
0.1-3.0, malic acid 0.1-5.0, tartaric acid 0.1-5.0 and salicylic acid or/and its esters 0.01-20.0, acetylsalicylic acid
0.01-19.0, Arginine Acetylsalicylate 0.02-25.0, lysine acetylsalicylate 0.02-30.0, calcium acetylsalicylate urea
Arbitrary or a combination thereof in 0.02-30.0;
Described solvent is by following mass percent(%)Raw material constitute:Grape wine 0.01-25.0, polyethylene glycol 0.01-
10.0th, lactic acid 0.1-3.0, glycerine 0.01-5.0, ethanol 0.01-30.0 and water 0.1-98.5.
3. removing acne and eliminating mark skin conditioner according to claim 1 it is characterised in that:Height in described removing acne and eliminating mark skin conditioner
In the hyaluronic acid of low three kinds of different molecular weight sizes or/and hyaluronate refer to polymer hyaluronic acid or hyaluronate
Molecular weight be more than 1,800,000 dalton, the molecular weight of middle molecular weight hyaluronic acid or hyaluronate is between 1,000,000-1
Between 800 000 dalton, the molecular weight of low molecular weight hyaluronic acid or hyaluronate is less than 600,000 dalton.
4. removing acne and eliminating mark skin conditioner according to claim 1 it is characterised in that:Described high, normal, basic three kinds of different molecular weights are big
Little polyglutamic acid or/and polyglutamate refer to that polyphosphazene polymer glutamic acid or the molecular weight of polyglutamate are more than 1,000,
000 dalton, the molecular weight of middle molecule polyglutamic acid or polyglutamate between 600,000-1,000,000 dalton,
The molecular weight of low molecular weight polycaprolactone glutamic acid or polyglutamate is less than 100,000 dalton.
5. the removing acne and eliminating mark skin conditioner according to claim 1 and 2 it is characterised in that:Grape wine in described solvent includes
Red wine and white wine, the polyethylene glycol in solvent refers to that the molecular weight of more than food-grade is in 400-20000 dalton
Any one or a combination thereof, lactic acid in solvent, grape-kernel oil, glycerine and ethanol is more than food-grade, and water is counter-infiltration level
Above pure water or its distilled water.
6. Energy and comfort according to claim 1 removing acne and eliminating mark skin conditioner formulation it is characterised in that:Described Energy and comfort
Removing acne and eliminating mark skin conditioner formulation mean aqua, vina, tincture, suspension, emulsion, creme, paste, gel, coagulant liquid, oil
Agent, film, spray or patch.
7. a kind of preparation method of removing acne and eliminating mark skin conditioner according to claim 1 is it is characterised in that comprise the steps of:
(1)Formula as described in this patent and formula ratio weigh each component of skin care and removing acne and eliminating mark composition respectively, standby
With;
(2)Formula as described in this patent and formula ratio weigh each component of this removing acne and eliminating mark skin conditioner solvent for use respectively, often
Standby after temperature or low temperature mixing;
(3)Each component of the skin care composition of formula ratio is added solvent, normal temperature or the low temperature of part formulation amount
Mix, obtain mixture A;
(4)Each component of the removing acne and eliminating mark composition of formula ratio is added solvent, normal temperature or the low temperature of part formulation amount
Mix, obtain mixture B;
(5)Mixture B is slowly added in mixture A, then residual solvent is added thereto, normal temperature or low temperature are equal
Even, obtain final product described removing acne and eliminating mark skin conditioner.
8. removing acne and eliminating mark skin conditioner according to claim 7 preparation method it is characterised in that:Described step(2)(3)
(4)(5)In normal temperature or cryogenic conditions be preferably less than 42 DEG C, again more preferably less than 21 DEG C but be more than 10 DEG C.
9. removing acne and eliminating mark skin conditioner according to claim 7 preparation method it is characterised in that:Described step(2)(3)
(4)(5)In the operating condition that stirs and evenly mixs be preferably two-dimentional mix and blend in medical stainless steel blender, more preferably exist
Three-dimensional hybrid stirring in glass reactor or 316L stainless steel blender, further preferably for emulsifying side under vacuum
Formula is realized.
10. Energy and comfort according to claim 1 removing acne and eliminating mark skin conditioner formulation it is characterised in that:Described convenience is relaxed
Suitable removing acne and eliminating mark skin conditioner formulation includes liquid formulation and solid formulation, preferably half fluidised form preparation, more preferably aqueous solidifying
Jelly, in practical application, can as needed and use Energy and comfort, with described removing acne and eliminating mark skin conditioner remove molten
Composition outside agent is base-material, then mixes removing acne and eliminating mark skin conditioner acceptable carrier of the present invention or auxiliary material, is made using corresponding
Agent technology make the convenient aqua being suitable for, vina, tincture, suspension, emulsion, creme, paste, gel, coagulant liquid, finish,
Film, spray or patch.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611027865.2A CN106389139A (en) | 2016-11-22 | 2016-11-22 | Acne-removing, mark-eliminating and skin-protecting multifunctional preparation and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611027865.2A CN106389139A (en) | 2016-11-22 | 2016-11-22 | Acne-removing, mark-eliminating and skin-protecting multifunctional preparation and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106389139A true CN106389139A (en) | 2017-02-15 |
Family
ID=58068763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611027865.2A Pending CN106389139A (en) | 2016-11-22 | 2016-11-22 | Acne-removing, mark-eliminating and skin-protecting multifunctional preparation and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106389139A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107519081A (en) * | 2017-08-25 | 2017-12-29 | 杭州惠博士健康产业有限公司 | A kind of composition and preparation method that effect is repaired with anti-acne |
CN108403621A (en) * | 2018-05-07 | 2018-08-17 | 广州度普生物科技有限公司 | A kind of antibacterial blemish clearing gel of multiple target point and preparation method thereof |
CN109820791A (en) * | 2019-01-17 | 2019-05-31 | 东晟源研究院(广州)有限公司 | A kind of moisture retention water and preparation method thereof convenient for absorption |
CN110721115A (en) * | 2019-12-10 | 2020-01-24 | 朱怀杰 | Biological beauty skin cream for preventing and treating whelk and preparation method thereof |
CN113908097A (en) * | 2021-12-06 | 2022-01-11 | 华熙生物科技股份有限公司 | Acne-removing composition and application thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102973425A (en) * | 2011-09-05 | 2013-03-20 | 张弘 | Whitening anti-aging nanoscale skin-care agent |
CN104840385A (en) * | 2015-04-11 | 2015-08-19 | 广东医学院 | A group of coenzyme Q10 skin protection creams with effects of skin moisturizing, wrinkle preventing and aging resistance |
CN105362143A (en) * | 2015-11-26 | 2016-03-02 | 珠海蕾特恩国际贸易有限公司 | Acne-removing essence and preparation method thereof |
CN105726366A (en) * | 2016-04-07 | 2016-07-06 | 天津嘉氏堂医美科技有限公司 | Skin lipid membrane repairing composition |
CN105963204A (en) * | 2016-06-27 | 2016-09-28 | 中国人民解放军总医院 | Anti-allergic mask with moisturizing and repairing functions and preparation method of anti-allergic mask |
-
2016
- 2016-11-22 CN CN201611027865.2A patent/CN106389139A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102973425A (en) * | 2011-09-05 | 2013-03-20 | 张弘 | Whitening anti-aging nanoscale skin-care agent |
CN104840385A (en) * | 2015-04-11 | 2015-08-19 | 广东医学院 | A group of coenzyme Q10 skin protection creams with effects of skin moisturizing, wrinkle preventing and aging resistance |
CN105362143A (en) * | 2015-11-26 | 2016-03-02 | 珠海蕾特恩国际贸易有限公司 | Acne-removing essence and preparation method thereof |
CN105726366A (en) * | 2016-04-07 | 2016-07-06 | 天津嘉氏堂医美科技有限公司 | Skin lipid membrane repairing composition |
CN105963204A (en) * | 2016-06-27 | 2016-09-28 | 中国人民解放军总医院 | Anti-allergic mask with moisturizing and repairing functions and preparation method of anti-allergic mask |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107519081A (en) * | 2017-08-25 | 2017-12-29 | 杭州惠博士健康产业有限公司 | A kind of composition and preparation method that effect is repaired with anti-acne |
CN108403621A (en) * | 2018-05-07 | 2018-08-17 | 广州度普生物科技有限公司 | A kind of antibacterial blemish clearing gel of multiple target point and preparation method thereof |
CN109820791A (en) * | 2019-01-17 | 2019-05-31 | 东晟源研究院(广州)有限公司 | A kind of moisture retention water and preparation method thereof convenient for absorption |
CN110721115A (en) * | 2019-12-10 | 2020-01-24 | 朱怀杰 | Biological beauty skin cream for preventing and treating whelk and preparation method thereof |
CN113908097A (en) * | 2021-12-06 | 2022-01-11 | 华熙生物科技股份有限公司 | Acne-removing composition and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106389139A (en) | Acne-removing, mark-eliminating and skin-protecting multifunctional preparation and preparation method thereof | |
CA2538093A1 (en) | Porifera-based therapeutic compositions for treating and preventing skin diseases | |
Pounikar et al. | Formulation and characterization of Aloe vera cosmetic herbal hydrogel | |
CN105687059A (en) | Cosmetic composition for relieving senescence, as well as preparation method and application thereof | |
CN108553411A (en) | Azelaic acid gelling agent and its preparation method and application | |
CN107303253A (en) | It is a kind of to be used to be damaged renovation agent of skin and preparation method thereof | |
CN106420491A (en) | Multifunctional skin care product with effects of whitening skin, removing freckles, preserving moisture and removing wrinkle and preparation method of multifunctional skin care product | |
CN107375032A (en) | A kind of composition and preparation method for repairing skin barrier | |
CN107822945A (en) | One kind is matched unartificial yeast composition, preparation method and applied in cosmetics | |
JP2010173991A (en) | External preparation for skin | |
CN110302223A (en) | A kind of hair nourishing liquid preparation and preparation method thereof for repairing hair follicle | |
CN107970140A (en) | A kind of dispel scar composition and its application containing alligator oil | |
CN107412255A (en) | Skin barrier remediation composition and preparation | |
CN107519236A (en) | A kind of topical agent for treating onychomycosis | |
CN106726896A (en) | A kind of beautifying health composition with anti-inflammatory bacteriostasis efficacy and preparation method thereof | |
CN104188859B (en) | A kind of crease-resistant skin care emulsion containing natural component extract and preparation method thereof | |
CN106109587A (en) | A kind of pharmaceutical composition repairing microecology in vaginas of women balance | |
CN108542805A (en) | Anti-acne compound essential oil preparation and its preparation method and application | |
CN106420399A (en) | Laser cosmetology nursing agent, preparation and use method thereof | |
CN112773733A (en) | Acne-removing composition and preparation method of emulsion thereof | |
CN106491511A (en) | A kind of flesh can repair water light essence | |
CN103191159B (en) | Inflammation-diminishing bacterium-inhibition preparation and its preparation method and use | |
CN105796461A (en) | Moisturizing and repairing lotion containing hydrolyzed pearl essence flexible nano-liposomes and sea buckthron oil | |
CN106362141A (en) | Safe and multi-effect freckle removing agent and preparation method thereof | |
CN113995775B (en) | Probiotics foot mask with foot protection effect and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170215 |
|
RJ01 | Rejection of invention patent application after publication |